Jamieson Wellness Inc. Announces Date of Second Quarter 2022 Financial Results and Conference Call Life Science Investing
Health Canada Approves AbbVie's RINVOQ® for the Treatment of Adults with Active Ankylosing Spondylitis Pharmaceutical Investing
Gilead Sciences Contributes Additional $85 Million to Its Foundation to Advance Health Equity Pharmaceutical Investing
Abbott Reports Second-Quarter 2022 Results and Raises Full-Year EPS Guidance Pharmaceutical Investing
AbbVie and iSTAR Medical Announce Strategic Alliance for the Treatment of Glaucoma Pharmaceutical Investing
Bristol Myers Squibb Launches Disability Diversity in Clinical Trials Initiative to Improve Healthcare Outcomes for People with Disabilities Pharmaceutical Investing
Merck Provides Update on Phase 3 KEYNOTE-412 Trial in Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Life Science Investing
Jamieson Wellness Inc. Completes Acquisition of Nutrawise Health & Beauty Corporation, Owner of youtheory Brand Life Science Investing
Gilead Sciences Signs New Joint Procurement Agreement with the European Commission for Veklury® Pharmaceutical Investing
Lobe Sciences Files Patent Application Covering the Preparation of Stable Psilocin Prodrugs and Analogues and their Uses Further Strengthening its Intellectual Property Portfolio Pharmaceutical Investing
